title: [Discussion on the key aspects of risk control and problems of quality management systems for allogeneic bone products].
abstract: From the view of the potential risks of allogeneic bone products in clinical use. the key aspects of risk control and quality management for these products are discussed, as well as the general problems existing in the quality management system of their production enterprises in China are briefly introduced.
authors.affiliation: Center for Certification of Drug, State Food and Drug Administration of China, Beijing, 100061. sltian1@yahoo.com.cn
authors.forename: Shaolei
authors.initials: S
authors.lastname: Tian
mesh_terms: D016025:Bone Transplantation / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D011786:Quality Control; D018570:Risk Assessment; D014184:Transplantation, Homologous / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods*